Arnav Biotech specializes in the custom synthesis and optimization of mRNA for therapeutic, vaccine, diagnostic, and agricultural applications, providing high-quality mRNA solutions tailored to specific research needs. The company addresses the challenge of limited access to reliable mRNA resources by offering scalable production and expert design support for scientists in academia and industry.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers and companies developing mRNA-based therapeutics, vaccines, diagnostics, and agricultural products face challenges in accessing high-quality, custom-designed mRNA. The limited availability of reliable mRNA synthesis and optimization services can hinder research progress and slow down the development of novel applications.
Solution
Arnav Biotech provides custom mRNA synthesis and optimization services, offering tailored solutions for therapeutic, vaccine, diagnostic, and agricultural applications. The company leverages its expertise in mRNA design and manufacturing to support scientists in academia and industry, ensuring access to high-quality mRNA constructs. Arnav Biotech collaborates with customers to design and synthesize mRNA candidates optimized for specific research needs, offering both custom synthesis and a catalog of off-the-shelf mRNA products.
Target Audience
Arnav Biotech serves scientists and researchers in academia and industry who are developing mRNA-based therapeutics, vaccines, diagnostics, and agricultural products.
Features
- Custom mRNA synthesis services tailored to specific research requirements
- mRNA design and optimization expertise to improve expression and stability
- Catalog of off-the-shelf mRNA products for various applications
- Scalable mRNA production capabilities to meet diverse project needs
- Support for therapeutic, vaccine, diagnostic, and agricultural applications